1-5 of 5
Andy Dagis
Close
Sort by
Journal Articles

NK Cell Recovery and Costimulatory Molecule Profiles after Autologous Hematopoietic Cell Transplantation (AHCT) in Multiple Myeloma (MM) Patients

Myo Htut, MD, Ghislaine Gallez-Hawkins, Joycelynne Palmer, PhD, Laetitia Jeannet, Leanne Goldstein, Andy Dagis, Ricardo Spielberger, MD, Pablo Miguel Parker, Len Farol, MD, Firoozeh Sahebi, MD, Chatchada Karanes, MD, Stephen J. Forman, Amrita Krishnan, MD, John A. Zaia, MD
Journal: Blood
Blood (2014) 124 (21): 2039.
https://doi.org/10.1182/blood.V124.21.2039.2039
Published: 2014
Journal Articles

Therapy-Related Acute Lymphoblastic Leukemia: Cytogenetic Features and Hematopoietic Cell Transplantation Outcome

Ibrahim Aldoss, Vinod Pullarkat, MD, Andy Dagis, Joycelynne Palmer, Stephen J. Forman, MD
Journal: Blood
Blood (2014) 124 (21): 3655.
https://doi.org/10.1182/blood.V124.21.3655.3655
Published: 2014
Journal Articles

Analysis of Risk Factors and Outcome for Extramedullary Relapses Post Allogeneic Stem Cell Transplantation for Myeloma.

Myo Htut, MD, Firoozeh Sahebi, M.D., George Somlo, MD, Pablo Parker, M.D., Chatchada Karanes, MD, Andy Dagis, Susan Hmwe, Tanya Paris, Joyce Murata-Collins, PhD, Leslie Popplewell, M.D., Joycelynne Palmer, PhD., Stephen Forman, M.D., Amrita Krishnan, M.D.
Journal: Blood
Blood (2010) 116 (21): 4562.
https://doi.org/10.1182/blood.V116.21.4562.4562
Published: 2010
Journal Articles

Long Term Survival after ASCT for AML: Multivariate Analysis Shows Adverse Effect of Collecting and Infusing Larger Numbers of CD 34 Positive Cells.

Clarence B. Sarkodee-Adoo, MD, FACP, Anthony S. Stein, MD, Margaret R. O’Donnell, MD, Ravi M. Bhatia, MD, E. Bolotin, MD, K. P. Chang, MD, Mark Kirschbaum, MD, Neil Kogut, MD, Auayporn Nademanee, MD, Pablo Parker, MD, Vinod Pullarkat, MD, David Snyder, MD, Ricardo Spielberger, MD, Marilyn L. Slovak, MD, Joseph Alvarnas, MD, Joy Fridey, MD, Jeffrey Schriber, MD, Eileen Smith, MD, Andy Dagis, J. Land, J. Palmer, N. Vora, Stephen Forman, MD FACP
Journal: Blood
Blood (2005) 106 (11): 2921.
https://doi.org/10.1182/blood.V106.11.2921.2921
Published: 2005
Journal Articles

A phase 1/2 trial of high-dose yttrium-90-ibritumomab tiuxetan in combination with high-dose etoposide and cyclophosphamide followed by autologous stem cell transplantation in patients with poor-risk or relapsed non-Hodgkin lymphoma

Clinical Trials & Observations
Auayporn Nademanee, Stephen Forman, Arturo Molina, Henry Fung, David Smith, Andy Dagis, Cheuk Kwok, Dave Yamauchi, Anne-Line Anderson, Peter Falk, Amrita Krishnan, Mark Kirschbaum, Neil Kogut, Ryotaro Nakamura, Margaret O'Donnell, Pablo Parker, Leslie Popplewell, Vinod Pullarkat, Roberto Rodriguez, Firoozeh Sahebi, Eileen Smith, David Snyder, Anthony Stein, Ricardo Spielberger, Jasmine Zain, Christine White, Andrew Raubitschek
Journal: Blood
Blood (2005) 106 (8): 2896–2902.
https://doi.org/10.1182/blood-2005-03-1310
Published: 2005